n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with 4-iodoamphetamine in 1 studies
Studies (n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine) | Trials (n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine) | Recent Studies (post-2010) (n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine) | Studies (4-iodoamphetamine) | Trials (4-iodoamphetamine) | Recent Studies (post-2010) (4-iodoamphetamine) |
---|---|---|---|---|---|
80 | 2 | 1 | 100 | 4 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blau, M | 1 |
1 review(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and 4-iodoamphetamine
Article | Year |
---|---|
Radiotracers for functional brain imaging.
Topics: Amphetamines; Animals; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Microspheres; Oxygen Radioisotopes; Radioisotopes; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Technetium; Tomography, Emission-Computed; Xenon Radioisotopes | 1985 |